Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production News

Giliad's Yesarta becomes second FDA-approved CAR T treatment and AstraZeneca admits efficacy data for an acquired cancer drug was fabricated. Check...
Novartis has announced its intention to shut down its US generics manufacturing plant in Broomfield, Colorado, a move that will lead to a loss of...
AstraZeneca and partner Hutchison China MedTech have announced positive data for savolitinib in combination with either AstraZeneca’s Tagrisso or...
Aimmune Therapeutics, a biotech company developing treatments for food allergies, announced that it has entered into a clinical trial collaboration...
The EMA received a broadside just less than two week ago from a group of researchers that had studied data from cancer drug approvals, and has now...
Sanofi Aventis Nigeria plans to put together a National Diabetes Summit to address crisis in the country as five million of the nation’s citizens...
Back in August, President Trump had suggested that the opioid epidemic that is ravaging the US would be declared a national emergency, two months...
It’s always crunch time for regulatory operations. Whether you’re managing plans and documents for an upcoming IND or producing routine product...
Childhood obesity has increased ten-fold, China to finally accept overseas trial data and GSK rated worst UK company for governance in new report....
Following on from the popularity of our previous free  webinar sessions, Pharmafocus is once...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches